CWWeekly January 22nd 2008 Issue
U.S. Supreme Court Will Not Hear Abigail Alliance v. Eschenbach
The Abigail Alliance’s petition for a writ of certiorari in The Supreme Court of the United States was denied on January 14. The question presented was “whether terminally ill patients who lack alternative treatment options have a constitutional right to purchase unapproved investigational drugs that have not been shown to be safe or effective and that have not been authorized for treatment uses by the Food and Drug Administration.”
Cetero Research Adds Metabolic Expertise with DGD Acquisition
Cary, N.C.-based early stage contract research organization (CRO) Cetero Research broadened its range of therapeutic area research with the acquisition of San Antonio, Texas-based CRO, DGD Research. Financial details were not disclosed. The acquired CRO, which conducts studies in both early- and late-stage trials, was formerly known as Diabetes & Glandular Disease Research Associates.
Other breaking news...
- Kendle expands phase I, Asia-Pacific business...
- Clinical Ink launches web initiative...
Company Profile: An interview with Michael O’Connell, director of Life Science Solutions Group, Insightful, Life Sciences Division
To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information. Past weekly article summaries for the year can be found in the CW Weekly Issue archives.
Comments